Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
British Journal of Pharmacology|October 17, 2017
Amelioration of autoimmunity with an inhibitor selectively targeting all active centres of the immunoproteasomeMichael Basler, Elmer Maurits, Gerjan de Bruin, et al.British Journal of Pharmacology|April 1, 2026
PLGA-particle-based vaccine induces SARS-CoV-2-specific antibody and T-cell responsesDennis Horvath, Katharina Inholz, Dennis Mink, et al.Cell|March 5, 2013
Immuno- and constitutive proteasomes do not differ in their abilities to degrade ubiquitinated proteinsJames A Nathan, Valentina Spinnenhirn, Gunter Schmidtke, et al.EMBO Molecular Medicine|January 9, 2014
Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitisMichael Basler, Sarah Mundt, Tony Muchamuel, et al.Cell|February 21, 2012
Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificityEva M Huber, Michael Basler, Ricarda Schwab, et al.British Journal of Cancer|January 21, 2023
Immunoproteasome inhibition prevents progression of castration-resistant prostate cancerJun Li, Nan Liu, Hong Zhou, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2012
Why the structure but not the activity of the immunoproteasome subunit low molecular mass polypeptide 2 rescues antigen presentationMichael Basler, Christoph Lauer, Jacqueline Moebius, et al.Cell Death Discovery|November 24, 2025
Immunoproteasome inhibition triggers protein stress and apoptosis in cells of B cell lineage without impairing vaccination-induced antibody responsesDennis Mink, Franziska Oliveri, Julia Otto, et al.Antioxidants (Basel, Switzerland)|February 26, 2025
Chemical and Biological Mechanisms Relevant to the Rescue of MG-132-Treated Neurons by CysteineAnna-Katharina Ückert, Ilinca Suciu, Anja Land, et al.Pageof 8